Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9209)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2021 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nishida A, Nishino K, Sakai K, Owaki Y, Noda Y, Imaeda H. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease? World J Gastroenterol 2021; 27(23): 3317-3326 [PMID: 34163114 DOI: 10.3748/wjg.v27.i23.3317] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i23/3317.htm |
| Number | Citing Articles |
| 1 |
Chi Yan, Shou-He Huang, Hua-Fang Ding, Erika Kwek, Jian-Hui Liu, Zi-Xing Chen, Ka Ying Ma, Zhen-Yu Chen. Adverse effect of oxidized cholesterol exposure on colitis is mediated by modulation of gut microbiota. Journal of Hazardous Materials 2023; 459: 132057 doi: 10.1016/j.jhazmat.2023.132057
|
| 2 |
Antonio Pellegrino, Gaetano Coppola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani. Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties. Nutrients 2023; 15(8): 1815 doi: 10.3390/nu15081815
|
| 3 |
Min Wang, Jingyan Shi, Chao Yu, Xinyi Zhang, Gaoxin Xu, Ziyan Xu, Yong Ma. Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1298186
|
| 4 |
Meitong Guo, Xingchen Du, Xiaoyan Wang. Inhibition of ferroptosis: A new direction in the treatment of ulcerative colitis by traditional Chinese medicine. Journal of Ethnopharmacology 2024; 324: 117787 doi: 10.1016/j.jep.2024.117787
|
| 5 |
Si Wang, Lei Li, Yuhan Chen, Qian Liu, Shengyu Zhou, Ning Li, Yueying Wu, Jiali Yuan. Houttuynia cordata thunb. alleviates inflammatory bowel disease by modulating intestinal microenvironment: a research review. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1306375
|
| 6 |
Siyao Gu, Xiaona Zhao, Fang Wan, Dayong Gu, Weidong Xie, Cheng Gao. Intracellularly Gelated Macrophages Loaded with Probiotics for Therapy of Colitis. Nano Letters 2024; 24(43): 13504 doi: 10.1021/acs.nanolett.4c02699
|
| 7 |
Eduardo J. Villablanca, Katja Selin, Charlotte R. H. Hedin. Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?. Nature Reviews Gastroenterology & Hepatology 2022; 19(8): 493 doi: 10.1038/s41575-022-00604-y
|
| 8 |
Huanhuan Liu, Chunhong Yan, Yue Teng, Jian Guo, Chencheng Liang, Xiaodong Xia. Gut microbiota and d-ribose mediate the anti-colitic effect of punicalagin in DSS-treated mice. Food & Function 2024; 15(13): 7108 doi: 10.1039/D4FO00741G
|
| 9 |
Shaowei Huang, Qiujuan Ye, Anjiang Wang, Ye Chen. Paeoniae Decoction restores intestinal barrier dysfunction by promoting the interaction between ILC3 and gut flora. Phytomedicine 2024; 132: 155873 doi: 10.1016/j.phymed.2024.155873
|
| 10 |
Lie Zheng, Xin-Li Wen, Sheng-Lei Duan. Role of metabolites derived from gut microbiota in inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(9): 2658 doi: 10.12998/wjcc.v10.i9.2658
|
| 11 |
Adrian Boicean, Dan Bratu, Sorin Radu Fleaca, Gligor Vasile, Leeb Shelly, Sabrina Birsan, Ciprian Bacila, Adrian Hasegan. Exploring the Potential of Fecal Microbiota Transplantation as a Therapy in Tuberculosis and Inflammatory Bowel Disease. Pathogens 2023; 12(9): 1149 doi: 10.3390/pathogens12091149
|
| 12 |
Peter C. Konturek. Darmmikrobiom und chronisch- entzündliche Darmerkrankung. MMW - Fortschritte der Medizin 2022; 164(S7): 12 doi: 10.1007/s15006-022-1230-3
|
| 13 |
Mei Wang, Ruijia Fu, Dingqiao Xu, Yanyan Chen, Shijun Yue, Sai Zhang, Yuping Tang. Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology. Journal of Ethnopharmacology 2024; 318: 116879 doi: 10.1016/j.jep.2023.116879
|
| 14 |
Céline Henry, Ariane Bassignani, Magali Berland, Olivier Langella, Harry Sokol, Catherine Juste. Modern Metaproteomics: A Unique Tool to Characterize the Active Microbiome in Health and Diseases, and Pave the Road towards New Biomarkers—Example of Crohn’s Disease and Ulcerative Colitis Flare-Ups. Cells 2022; 11(8): 1340 doi: 10.3390/cells11081340
|
| 15 |
Xiaochen Zhang, Dai Ishikawa, Toshifumi Ohkusa, Shinji Fukuda, Akihito Nagahara. Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1068567
|
| 16 |
Peijie Zhong, Hang Wu, Yuanqiao Ma, Xiaoxiao Xu, Yizhuo Jiang, Chaolei Jin, Qiaozhen Zhu, Xinlei Liu, Zhimin Suo, Junpeng Wang. P2X4 receptor modulates gut inflammation and favours microbial homeostasis in colitis. Clinical and Translational Medicine 2023; 13(4) doi: 10.1002/ctm2.1227
|
| 17 |
Meiyu Bao, Keyi Wang, Jingqiang Li, Yueying Li, Huanhuan Zhu, Meiling Lu, Yue Zhang, Qiangyuan Fan, Lin Han, Kesheng Wang, Dongyan Wang, Yan Gao, Bo Peng, Zunzhen Ming, Weiwei Liu. ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease. Acta Biomaterialia 2023; 161: 250 doi: 10.1016/j.actbio.2023.02.026
|
| 18 |
Xiaohua Guo, Edozie Samuel Okpara, Wanting Hu, Chuyun Yan, Yu Wang, Qionglin Liang, John Y. L. Chiang, Shuxin Han. Interactive Relationships between Intestinal Flora and Bile Acids. International Journal of Molecular Sciences 2022; 23(15): 8343 doi: 10.3390/ijms23158343
|
| 19 |
Zhihao Wang, Min Gao, Juan Kan, Qingyang Cheng, Xiaotong Chen, Chao Tang, Dan Chen, Shuai Zong, Changhai Jin. Resistant Starch from Purple Sweet Potatoes Alleviates Dextran Sulfate Sodium-Induced Colitis through Modulating the Homeostasis of the Gut Microbiota. Foods 2024; 13(7): 1028 doi: 10.3390/foods13071028
|
| 20 |
Mengmeng Zhang, Xuan Qu. Research Progress on Mechanism of Shikonin in Treatment of Colitis. Journal of Contemporary Medical Practice 2024; 6(10): 167 doi: 10.53469/jcmp.2024.06(10).34
|
| 21 |
Zhiguo Li, Shan Zhang, Li Xu, Xuexun Fang, Youzhong Wan, Dahai Yu, Yi Guo. A tetrapeptide from maize combined with probiotics exerted strong anti-inflammatory effects and modulated gut microbiota in DSS-induced colitis mice. Food & Function 2022; 13(24): 12602 doi: 10.1039/D2FO02678C
|
| 22 |
Javier Martínez de Victoria Carazo, David Vinuesa García, Esther Serrano-Conde Sánchez, José Antonio Peregrina Rivas, Antonio José Ruíz Rodríguez, José Hernández Quero. Ruminococcus gnavus bacteremia: Literature review and a case report associated with acute flare of ulcerative colitis in an immunocompromised patient. Anaerobe 2023; 82: 102762 doi: 10.1016/j.anaerobe.2023.102762
|
| 23 |
Qianhui Fu, Xiaoqin Ma, Shuchun Li, Mengni Shi, Tianyuan Song, Jian Cui. New insights into the interactions between the gut microbiota and the inflammatory response to ulcerative colitis in a mouse model of dextran sodium sulfate and possible mechanisms of action for treatment with PE&AFWE. Animal Models and Experimental Medicine 2024; 7(2): 83 doi: 10.1002/ame2.12405
|
| 24 |
Qinying Wang, Fanying Guo, Yutao Jin, Yanlei Ma. Applications of human organoids in the personalized treatment for digestive diseases. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01194-6
|
| 25 |
Xinyue Yang, Mengmeng Sun, Min He, Zhihong Wang, Qingqing Tang, Tie Li. Acupuncture for inflammatory bowel disease: A protocol for systematic review and meta-analysis. Medicine 2022; 101(49): e32236 doi: 10.1097/MD.0000000000032236
|
| 26 |
Hyeonwoo Kim, Ji Eun Na, Sangsoo Kim, Tae-Oh Kim, Soo-Kyung Park, Chil-Woo Lee, Kyeong Ok Kim, Geom-Seog Seo, Min Suk Kim, Jae Myung Cha, Ja Seol Koo, Dong-Il Park. A Machine Learning-Based Diagnostic Model for Crohn’s Disease and Ulcerative Colitis Utilizing Fecal Microbiome Analysis. Microorganisms 2023; 12(1): 36 doi: 10.3390/microorganisms12010036
|
| 27 |
Vincenza Tinnirello, Maria Grazia Zizzo, Alice Conigliaro, Mariangela Tabone, Nima Rabienezhad Ganji, Adele Cicio, Carlo Bressa, Mar Larrosa, Francesca Rappa, Giuseppe Vergilio, Roberta Gasparro, Alessia Gallo, Rosa Maria Serio, Riccardo Alessandro, Stefania Raimondo. Industrial-produced lemon nanovesicles ameliorate experimental colitis-associated damages in rats via the activation of anti-inflammatory and antioxidant responses and microbiota modification. Biomedicine & Pharmacotherapy 2024; 174: 116514 doi: 10.1016/j.biopha.2024.116514
|
| 28 |
Wen-wen Ma, Zhi-Qiang Huang, Kun Liu, De-Zhi Li, Tian-Lu Mo, Qing Liu. The role of intestinal microbiota and metabolites in intestinal inflammation. Microbiological Research 2024; 288: 127838 doi: 10.1016/j.micres.2024.127838
|
| 29 |
Pauline Raoul, Marco Cintoni, Marta Palombaro, Luisa Basso, Emanuele Rinninella, Antonio Gasbarrini, Maria Cristina Mele. Food Additives, a Key Environmental Factor in the Development of IBD through Gut Dysbiosis. Microorganisms 2022; 10(1): 167 doi: 10.3390/microorganisms10010167
|
| 30 |
Peng Qiu, Takatsugu Ishimoto, Lingfeng Fu, Jun Zhang, Zhenyong Zhang, Yang Liu. The Gut Microbiota in Inflammatory Bowel Disease. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.733992
|
| 31 |
Lie Zheng, Xin-Li Wen, Sheng-Lei Duan. Role of metabolites derived from gut microbiota in inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(9): 2660-2677 doi: 10.12998/wjcc.v10.i9.2660
|
| 32 |
Magdalena Stojek, Anna Jabłońska, Krystian Adrych. The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. Journal of Clinical Medicine 2021; 10(18): 4055 doi: 10.3390/jcm10184055
|
| 33 |
Shanshan Li, Fuzhong Zhang, Qixiong Zhang. Pathological features-based targeted delivery strategies in IBD therapy: A mini review. Biomedicine & Pharmacotherapy 2022; 151: 113079 doi: 10.1016/j.biopha.2022.113079
|